Reviva Pharmaceuticals Holdings, Inc.
RVPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $13,183 | $10,364 | $5,289 | $13,476 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $330 | $451 | $968 | $1,207 |
| Total Curr. Assets | $13,513 | $10,815 | $6,257 | $14,683 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $820 | $820 | $820 | $820 |
| Total NC Assets | $820 | $820 | $820 | $820 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $14,333 | $11,635 | $7,077 | $15,503 |
| Liabilities | – | – | – | – |
| Payables | $5,432 | $4,969 | $4,721 | $6,283 |
| Short-Term Debt | $0 | $113 | $224 | $458 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4,307 | $6,995 | $6,564 | $7,860 |
| Total Curr. Liab. | $9,738 | $12,077 | $11,509 | $14,602 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $45 | $17 | $28 | $89 |
| Total NC Liab. | $45 | $17 | $28 | $89 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $9,783 | $12,094 | $11,537 | $14,691 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $10 | $7 | $5 | $5 |
| Retained Earnings | -$180,770 | -$176,760 | -$170,706 | -$164,273 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $185,310 | $176,294 | $166,241 | $165,081 |
| Total Equity | $4,550 | -$459 | -$4,460 | $813 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $14,333 | $11,635 | $7,077 | $15,503 |
| Net Debt | -$13,183 | -$10,250 | -$5,065 | -$13,018 |